Author

M. T. B. Dillon

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:metagenomics· 1

Frequent Co-Authors

A. Legrand· 1 shared A. Melcher· 1 shared A. Rullan· 1 shared C. Bakal· 1 shared C. Chan· 1 shared C. J. Lord· 1 shared D. B. Krastev· 1 shared E. Appleton· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Legrand

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

PARP inhibitors enhance reovirus-mediated cell killing through the death-inducing signaling complex (DISC) with an associated NF-kappa B-regulated immune response.

J. Kyula-Currie, V. Roulstone, J. Wright, F. Butera, A. Legrand, R. Elliott, M. McLaughlin, G. Bozhanova, D. B. Krastev, S. Pettitt, T. Tenev, M. T. B. Dillon, S. Foo, E. C. Patin, V. Jennings, , K. J. Harrington

This paper identifies PARP inhibitors as sensitizers for oncolytic reovirus by enhancing DISC-mediated apoptosis and NF-kappa B-driven immune responses.

bioRxiv · Dec 21, 2023 · PreprintCancer Biology